Gadobutrol
HealthData.Gov
Updated Jun 12, 2026
About this dataset
Gadobutrol is a prescription intravenous contrast agent used to enhance magnetic resonance imaging (MRI) scans, helping doctors visualize body structures more clearly. Manufactured by Fresenius Kabi USA, LLC, it's available in solution form with a concentration of 604.72 mg/mL in vials of 2 mL, 7.5 mL, 10 mL, or 15 mL. This gadolinium-based drug works by improving MRI contrast for better diagnosis. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Gadobutrol
Access the FDA dataset for Gadobutrol β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025